antigen |
vaccine dose |
vaccination route |
macaque species |
challenge virus |
challenge
route |
viremia/ total |
disease/ total |
survival/ total |
reference |
ZEBOV-GP |
1x 107 pfu |
I.M |
cynomolgus |
ZEBOV |
I.M |
0/4 |
0/4 |
4/4 |
[25] |
MARV-GP |
5x 107 pfu |
I.M |
cynomolgus |
MARV Musoke |
I.M |
0/4 |
0/4 |
4/4 |
[25] |
MARV-GP |
2x 107 pfu |
I.M |
cynomolgus |
MARV Angola |
I.M |
0/3 |
0/3 |
3/3 |
[28] |
MARV-GP |
2x 107 pfu |
I.M |
cynomolgus |
MARV Ravn |
I.M |
0/3 |
0/3 |
3/3 |
[28] |
MARV-GP |
2x 107 pfu |
I.M |
cynomolgus |
MARV Musoke |
I.M |
0/1 |
0/1 |
1/1 |
[28] |
ZEBOV-GP |
2x 107 pfu |
I.M |
cynomolgus |
ZEBOV |
AEROSOL |
0/3 |
0/3 |
3/3 |
[26] |
MARV-GP |
2x 107 pfu |
I.M |
cynomolgus |
MARV Musoke |
AEROSOL |
0/4 |
0/4 |
4/4 |
[26] |
ZEBOV-GP |
2x 107 pfu |
I.N |
cynomolgus |
ZEBOV |
I.M |
n.a. |
0/4 |
4/4 |
[27] |
ZEBOV-GP |
2x 107 pfu |
ORAL |
cynomolgus |
ZEBOV |
I.M |
n.a |
0/4 |
4/4 |
[27] |
ZEBOV-GP |
2x 107 pfu |
I.M |
cynomolgus |
ZEBOV |
I.M |
n.a. |
0/2 |
2/2 |
[27] |
ZEBOV-GP
SEBOV-GP
MARV-GP |
1x 107 pfu
each |
I.M |
cynomolgus |
ZEBOV |
I.M |
0/3 |
0/3 |
3/3 |
[29] |
ZEBOV-GP
SEBOV-GP
MARV-GP |
1x 107 pfu
each |
I.M |
cynomolgus |
SEBOV |
I.M |
0/2 |
0/2 |
2/2 |
[29] |
ZEBOV-GP
SEBOV-GP
MARV-GP |
1x 107 pfu
each |
I.M |
cynomolgus |
CIEBOV |
I.M |
0/3 |
0/3 |
3/3 |
[29] |
ZEBOV-GP
SEBOV-GP
MARV-GP |
1x 107 pfu
each |
I.M |
cynomolgus |
MARV
Musoke |
I.M |
0/3 |
0/3 |
3/3 |
[29] |
ZEBOV-GP |
3x 107 pfu |
I.M |
cynomolgus |
SEBOV |
I.M |
1/1 |
1/1 |
0/1 |
[29] |
SEBOV-GP
ZEBOV-GP
MARV-GP |
1x 107 pfu
each |
I.M |
rhesus |
SEBOV |
I.M |
0/3 |
0/3 |
3/3 |
[29] |
ZEBOV-GP |
2x 107 pfu |
I.M |
cynomolgus |
BEBOV |
I.M |
4/4 |
4/4 |
3/4 |
[30] |
CIEBOV-GP |
2x 107 pfu |
I.M |
cynomolgus |
BEBOV |
I.M |
3/3 |
3/3 |
1/3 |
[30] |